Report for Luther JM

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : The soluble epoxide hydrolase inhibitor GSK2256294 decreases the proportion of adipose pro-inflammatory T cells - Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604
Author(s) : Mashayekhi M , Wanjalla CN , Warren CM , Simmons JD , Ghoshal K , Pilkinton M , Bailin SS , Gabriel CL , Pozzi A , Koethe JR , Brown NJ , Kalams SA , Luther JM
Ref : Prostaglandins Other Lipid Mediat , 158 :106604 , 2021
Abstract : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604
ESTHER : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604
PubMedSearch : Mashayekhi_2021_Prostaglandins.Other.Lipid.Mediat_158_106604
PubMedID: 34922004

Title : GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans -
Author(s) : Luther JM , Ray J , Wei D , Koethe JR , Hannah L , DeMatteo A , Manning R , Terker AS , Peng D , Nian H , Yu C , Mashayekhi M , Gamboa J , Brown NJ
Ref : Hypertension , 78 :1092 , 2021
PubMedID: 34455816

Title : Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans - Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38
Author(s) : Ramirez CE , Shuey MM , Milne GL , Gilbert K , Hui N , Yu C , Luther JM , Brown NJ
Ref : Prostaglandins Other Lipid Mediat , 113-115 :38 , 2014
Abstract : Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38
ESTHER : Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38
PubMedSearch : Ramirez_2014_Prostaglandins.Other.Lipid.Mediat_113-115_38
PubMedID: 25173047
Gene_locus related to this paper: human-EPHX2